Meta-analysis of transradial vs transfemoral access for percutaneous coronary intervention in patients with chronic kidney disease
The American Journal of Cardiology Aug 16, 2021
Latif A, Ahsan MJ, Mirza MM, et al. - Use of transradial (TR) approach for percutaneous coronary intervention (PCI) in chronic kidney disease (CKD) patients resulted in a lower risk of in-hospital mortality, post-procedural bleeding, and blood transfusion when compared with transfemoral (TF) access.
PubMed, Embase, Cochrane, ClinicalTrials.gov, and Google Scholar were explored.
Studies of adults with CKD receiving PCI via a TR vs TF approach were included.
A random-effects-model using the Mantel‐Haenszel method was employed.
Eligible were five observational studies with 1,156 and 6,156 patients in the TR and TF arms, respectively.
Participants had a mean age of 70.5 years, 66% were male and 90% had end-stage renal disease.
No difference in stroke, myocardial infarction, or fluoroscopy time was observed between TR approach vs TF access.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries